For this analysis, outcomes were compared between individuals who had pulmonary arterial hypertension (PAH) and healthy controls by using Fitbit-derived data over 12 weeks and then at a 1-year follow-up.Read More
Wearable Tech Has Potential to Indicate PAH-Related Decline
